object
estim
preval
infect
respiratori
virus
pediatr
patient
cancer
acut
respiratori
infect
ari
andor
fever
method
crosssect
studi
januari
decemb
secret
nasopharyng
aspir
analyz
children
younger
year
acut
respiratori
infect
patient
treat
grupo
em
defesa
da
com
grendacc
univers
hospit
hu
sp
rapid
test
use
detect
influenza
viru
kit
biotrin
inc
ireland
realtim
multiplex
polymeras
chain
reaction
ftd
respiratori
pathogen
multiplex
fast
trade
kit
malta
detect
influenza
viru
b
rhinoviru
parainfluenza
viru
adenoviru
respiratori
syncyti
viru
human
parechoviru
bocaviru
metapneumoviru
human
coronaviru
preval
viral
infect
estim
associ
test
use
fisher
exact
test
result
sampl
nasopharyng
aspir
blood
analyz
median
age
year
male
white
repeat
ari
prior
antibiot
use
cough
contact
ari
total
good
gener
statu
acut
lymphocyt
leukemia
preval
neoplasia
respiratori
virus
detect
sampl
rhinovirus
respiratori
syncyti
viru
ab
coronaviru
codetect
occur
case
virus
virus
pleas
cite
articl
benit
ec
cabrini
dp
silva
ac
silva
jc
catalan
dt
berezin
en
et
al
acut
respiratori
viral
infect
pediatr
cancer
patient
undergo
chemotherapi
j
pediatr
rio
j
develop
develop
countri
respiratori
diseas
contribut
high
proport
morbid
mortal
childhood
estim
death
observ
children
younger
five
year
caus
acut
respiratori
infect
ari
complic
brazil
expect
new
case
childhood
cancer
case
per
year
children
younger
year
among
common
acut
lymphoblast
leukemia
central
nervou
system
cn
tumor
follow
hodgkin
lymphoma
hl
nonhodgkin
lymphoma
nhl
presenc
diseas
may
factor
immunosuppress
especi
lymphoma
convers
treatment
chemotherapi
interfer
patient
immun
respons
capac
infect
common
complic
associ
cancer
treatment
repres
main
caus
death
rather
cancer
acut
viral
respiratori
infect
common
caus
febril
episod
children
younger
five
year
even
children
treat
antineoplast
drug
mani
studi
concept
protocol
well
establish
manag
fever
episod
children
cancer
howev
still
doubt
regard
true
incid
role
viral
agent
respiratori
infect
patient
studi
publish
subject
past
littl
attent
given
literatur
new
virus
human
coronaviru
hcov
metapneumoviru
hmpv
ab
immunocompromis
pediatr
patient
studi
aim
determin
frequenc
infect
caus
respiratori
virus
patient
younger
year
cancer
acut
respiratori
infect
identifi
whether
subgroup
sever
ari
observ
crosssect
studi
perform
nasopharyng
aspir
sampl
patient
younger
year
cancer
fever
measur
report
respiratori
symptom
ari
collect
use
standard
protocol
clinic
record
collect
medic
record
one
author
est
um
artigo
open
access
sob
de
cc
byncnd
est
um
artigo
open
access
sob
de
cc
byncnd
patient
treat
children
hospit
grendacc
hg
hospit
da
faculdad
de
medicina
de
huj
citi
paulo
brazil
fund
brazilian
unifi
health
system
sistema
de
su
januari
decemb
huj
matern
child
hospit
region
referr
center
eight
citi
offer
secondari
care
popul
approxim
inhabit
surround
area
hg
dayhospit
referr
outpati
clinic
offer
assist
cancer
treatment
childhood
studi
approv
research
ethic
committe
faculdad
de
medicina
de
n
studi
subject
cancer
patient
younger
year
acut
respiratori
infect
ari
new
episod
ari
consid
interv
day
studi
period
ari
histori
respiratori
prodrom
least
one
follow
sign
symptom
fever
coryza
cough
sore
throat
andor
gastrointestin
symptom
fever
least
one
episod
fever
measur
report
axillari
temperatur
c
base
one
measur
c
base
two
measur
interv
hypothermia
temperatur
c
clinic
aspect
good
overal
statu
sick
toxem
good
overal
statu
defin
child
initi
appoint
show
chang
overal
appear
activ
without
distress
pain
patient
consid
sick
hesh
irrit
anxiou
fatigu
suffer
appear
toxem
patient
difficulti
breath
toxemia
lethargi
alter
conscious
anemia
hb
mgdl
neutropenia
absolut
neutrophil
count
anc
cellsmm
thrombocytopenia
total
platelet
count
suspicion
invas
bacteri
infect
absenc
neg
cultur
follow
clinic
criteria
observ
clinic
laboratori
find
sepsi
hemodynam
unstabl
child
poor
gener
statu
proven
invas
bacteri
infect
occurr
bacteremia
one
posit
blood
cultur
bacteri
pathogen
sepsi
coagulaseneg
staphylococcu
requir
two
posit
blood
cultur
collect
day
probabl
sepsi
indic
two
blood
cultur
coagulaseneg
staphylococcu
within
fourday
interv
three
blood
cultur
within
seven
day
four
blood
cultur
within
ten
day
sampl
size
requir
studi
n
episod
respiratori
infect
base
estim
preval
studi
virus
obtain
review
sever
studi
consid
sampl
error
possibl
sampl
patient
select
consecut
outpati
clinic
hg
monday
friday
pm
hospit
admiss
emerg
unit
hospit
day
time
fig
show
flowchart
patient
select
investig
followup
patient
sampl
drawn
nostril
aspir
one
nasopharyng
swab
obtain
patient
enrol
studi
supin
posit
head
posit
midlin
time
collect
sampl
swab
submit
rapid
test
detect
influenza
b
influenza
pandem
test
bioeasi
brazil
result
report
immedi
physician
treatment
decis
within
maximum
period
hour
collect
sampl
mix
ad
ringer
lactat
solut
total
ml
homogen
sampl
approxim
ml
separ
aliquot
cryotub
previous
identifi
store
liquid
nitrogen
store
c
pediatr
infecti
diseas
research
laboratori
fmj
dna
total
rna
nucleic
acid
extract
sampl
use
extract
kit
rtp
dna
rna
viru
mini
kit
molecular
stratec
germani
sensit
specif
monitor
standard
qualiti
control
molecular
diagnost
qualit
detect
blood
cultur
peripher
central
sampl
perform
use
kit
bactecalert
inc
unit
state
urinalysi
urin
cultur
obtain
admiss
well
cultur
differ
site
necessari
analysi
peripher
blood
perform
autom
hematolog
analyz
model
kx
usa
within
hour
collect
laboratori
investig
strictli
follow
manufactur
specif
measur
central
tendenc
dispers
use
describ
studi
sampl
preval
viral
infect
respect
confid
interv
estim
compar
proport
chisquar
fisher
exact
test
use
softwar
use
spss
releas
spss
chicago
il
unit
state
total
patient
undergo
cancer
treatment
agre
particip
studi
total
episod
fever
andor
respiratori
symptom
median
age
year
youngest
patient
year
old
respiratori
viral
pathogen
obtain
analyz
case
least
one
type
respiratori
viru
hrv
common
pathogen
found
infecti
episod
tabl
analysi
sampl
rapid
test
ifa
indirect
fluoresc
antibodi
ifah
n
ifb
monoclon
antibodi
pool
one
specif
type
influenza
virus
one
specif
type
b
influenza
virus
provid
use
ifa
assay
result
six
sampl
posit
influenza
viru
four
influenza
two
influenza
b
regard
number
virus
case
one
type
number
case
codetect
respiratori
virus
two
three
frequent
observ
rhinoviru
coronaviru
tabl
presenc
fever
respiratori
viru
posit
observ
episod
p
least
one
peak
fever
respiratori
symptom
case
time
consult
statist
signific
found
presenc
fever
sever
neutropenia
analyz
episod
p
among
sever
neutropen
case
posit
type
respiratori
viru
two
respiratori
syncyti
viru
b
one
coronaviru
one
rhinoviru
howev
consid
mild
moder
neutropen
case
statist
associ
p
observ
major
case
mild
respiratori
symptom
blood
cultur
collect
three
posit
bacteri
pathogen
associ
febril
episod
one
case
klebsiella
pneumonia
one
case
multiresist
klebsiella
pneumonia
one
case
gramneg
bacilli
episod
studi
empir
antibiot
therapi
case
case
patient
respiratori
viral
infect
none
posit
blood
urin
cultur
receiv
antibiot
therapi
total
episod
analyz
regard
hematolog
characterist
leukopenia
observ
patient
neutropenia
sever
neutropenia
patient
lymphopenia
present
case
also
observ
patient
anemia
thrombocytopenia
although
observ
patient
good
gener
health
statu
hypothermia
observ
anemia
sampl
one
individu
clinic
pictur
bacteremia
howev
death
attribut
studi
episod
regard
epidemiolog
ari
episod
observ
patient
previou
histori
contact
ari
although
statist
signific
p
correl
total
number
viru
posit
patient
versu
season
summer
spring
winter
fall
mani
concept
viral
respiratori
diseas
healthi
children
infanc
recent
modifi
patient
cancer
although
studi
last
decad
demonstr
import
ari
actual
role
infect
remain
unclear
seri
respiratori
infect
andor
fever
preval
respiratori
virus
observ
show
pathogen
often
detect
ari
children
undergo
chemotherapi
find
studi
consist
literatur
compar
studi
use
laboratori
method
qpcr
techniqu
koskenvuo
et
al
document
presenc
respiratori
infect
case
children
adolesc
leukemia
fever
srinivasan
et
al
observ
rate
studi
hrv
common
viral
pathogen
follow
coronaviru
rsv
metapneumoviru
demonstr
import
pathogen
studi
popul
studi
hrv
perform
immunosuppress
patient
bone
marrow
solid
organ
transplant
human
immunodefici
viru
hiv
carrier
although
increas
evid
possibl
involv
pathogen
lower
respiratori
tract
infect
group
pathogenesi
remain
unclear
present
studi
clinic
pictur
mild
author
observ
lower
respiratori
tract
infect
patient
affect
type
viru
other
although
hrv
may
remain
airway
healthi
children
resolut
acut
symptom
discuss
whether
direct
viral
damag
occur
predisposit
secondari
invas
worsen
sever
clinic
prognosi
author
found
higher
frequenc
respiratori
virus
srv
hrv
piv
adv
although
clinic
aspect
littl
explor
public
torr
et
al
report
presenc
srv
hrv
episod
fever
neutropenia
observ
piv
present
episod
serotyp
show
similar
frequenc
contrari
studi
preval
immunocompromis
children
emphasi
lower
airway
infect
increas
morbid
mortal
attribut
pathogen
recent
year
maeng
et
al
retrospect
studi
pediatr
patient
cancer
found
posit
result
case
piv
mortal
wherea
srinivasan
et
al
verifi
complic
occur
lower
respiratori
tract
infect
young
children
epidem
influenza
rais
new
question
earli
treatment
time
use
antivir
drug
base
clinic
criteria
presenc
risk
factor
complic
diseas
immunosuppress
present
seri
antivir
drug
rare
use
pediatr
oncologist
fact
might
explain
lack
previou
experi
handl
drug
disregard
import
viral
pathogen
time
access
drug
treatment
initi
impact
measur
viral
resist
drug
children
cancer
remain
unknown
relev
aspect
impact
season
influenza
variant
children
cancer
well
understood
children
shed
viru
week
month
studi
involv
children
cancer
children
undergo
bone
marrow
transplant
tran
et
al
observ
infect
lower
airway
case
influenza
howev
associ
increas
mortal
investig
children
hematolog
malign
also
reinforc
observ
although
increas
number
hospit
chemotherapi
delay
increas
antimicrobi
use
death
rare
studi
infect
rsv
caus
death
approxim
transplant
patient
confirm
impress
worsen
case
recent
year
present
studi
patient
improv
death
complic
relat
rsv
explain
part
greater
involv
patient
twoyear
age
rang
infect
less
sever
although
human
coronaviru
hcov
recogn
common
caus
infect
upper
respiratori
tract
lesser
extent
lower
tract
immunocompet
patient
impact
unknown
immunocompromis
children
case
bocaviru
observ
contrari
find
literatur
fact
might
explain
noncircul
pathogen
studi
period
limit
multiplex
molecular
identif
method
characterist
studi
popul
real
role
viru
children
cancer
unknown
use
qpcr
techniqu
allow
codetect
one
viru
sampl
howev
question
need
clarif
repres
coinfect
codetect
asymptomat
elimin
impact
codetect
clinic
sever
respiratori
diseas
patient
cancer
codetect
observ
present
studi
hrv
hcov
similar
rate
observ
studi
children
without
immunosuppress
hrv
second
third
frequent
viru
children
cancer
koskenvuo
et
al
found
codetect
rate
especi
hrv
rsv
present
cohort
codetect
associ
case
sever
initi
clinic
present
patient
mild
children
initi
good
gener
health
statu
rare
complic
lower
airway
death
de
pauli
et
al
observ
impact
clinic
sever
coinfect
hospit
infant
contrast
studi
also
carri
hospit
infant
without
immunosuppress
show
increas
number
codetect
may
result
increas
clinic
sever
young
children
fact
may
attribut
accident
find
virus
materi
without
import
clinic
signific
sever
cancer
patient
excret
viru
long
period
viral
infect
may
increas
suscept
bacteri
coinfect
multicent
studi
children
leukemia
fever
koskenvuo
et
al
found
bacteri
sepsi
patient
ari
studi
febril
neutropenia
avadhanula
et
al
found
associ
bacteri
infect
onethird
case
suggest
rsv
infect
increas
express
receptor
streptococcu
pneumonia
haemophilu
influenza
primari
bronchial
epitheli
cell
facilit
bacteri
colon
diseas
present
studi
bacteri
complic
clinic
examin
observ
favor
outcom
similar
patient
without
cancer
author
emphas
find
hypothermia
children
without
progress
sepsi
blood
cultur
posit
case
similar
studi
therefor
detect
viral
pathogen
may
provid
physician
safer
therapeut
approach
appropri
antimicrobi
use
reduc
unnecessari
cost
impos
health
system
provid
direct
improv
morbid
mortal
children
cancer
although
season
respiratori
virus
show
preval
fall
winter
observ
pattern
homogen
studi
virus
longer
period
observ
would
necessari
establish
season
pattern
group
children
respiratori
virus
pathogen
found
pediatr
cancer
patient
receiv
chemotherapi
demonstr
presenc
may
caus
factor
infecti
episod
codetect
frequent
cancer
patient
ari
possibl
identifi
whether
sever
acut
infect
directli
relat
type
cancer
viral
pathogen
projeto
regular
de
pesquisa
fapesp
author
declar
conflict
interest
